Prexige, Pulled In Australia, Still Viable: Novartis
Novartis AG has continued to insist that its painkiller Prexige is a viable option for some patients, after the drug was yanked from the Australian market and authorities there urged patients...To view the full article, register now.
Already a subscriber? Click here to view full article